Moreover, instead of promoting immunity against tumours, STING activation in B cells induced the secretion of anti-inflammatory cytokine IL-35 that impeded the actions of NK cells and led to poorer outcomes in mouse models22. This evidence concerns the gene STING1 and neoplasm.